GSK3326595 (Pemrametostat) is a potent PRMT5 inhibitor. It affects PI3K/AKT and HIF-1α/VEGF signaling by reducing symmetric dimethylarginine (SDMA) levels and inducing DNA damage, effectively inhibiting tumor cell proliferation and angiogenesis.
GSK3326595 (Pemrametostat, EPZ015938) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for GSK3326595 (Pemrametostat, EPZ015938) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- GSK3326595 (Pemrametostat, EPZ015938) Mechanism of Action: PRMT5 Inhibition in Cancer Cell Research
- GSK3326595 (Pemrametostat, EPZ015938) Clinical Trials
- GSK3326595 (Pemrametostat, EPZ015938) Working Concentration | Cell Culture | Treatment
- GSK3326595 (Pemrametostat, EPZ015938) Solubility in DMSO
- GSK3326595 (Pemrametostat, EPZ015938) Stock Solution
- GSK3326595 (Pemrametostat, EPZ015938) Storage
- GSK3326595 (Pemrametostat, EPZ015938) Stability
- GSK3326595 (Pemrametostat, EPZ015938) Combination Database
- GSK3326595 (Pemrametostat, EPZ015938) Molecular Weight
- GSK3326595 (Pemrametostat, EPZ015938) SMILES
- GSK3326595 (Pemrametostat, EPZ015938) CAS Number
- GSK3326595 (Pemrametostat, EPZ015938) Chemical Structure (2D and 3D)
- GSK3326595 (Pemrametostat, EPZ015938) Cayman (27305)? Try a better option.
- GSK3326595 (Pemrametostat, EPZ015938) Sigma (AMBH303C5C18)? Try a better option.
- GSK3326595 (Pemrametostat, EPZ015938) APExBIO (BA2257)? Try a better option.
- GSK3326595 (Pemrametostat, EPZ015938) SDS｜MSDS